Form 4: Entera Bio Director Receives Stock Grant
Insider Transaction (Form 4)
Sean Ellis, a Director of Entera Bio Ltd., reported multiple transactions in common stock on August 7, 2026.
Summary
- Grant/award: acquired 20,034 Ordinary Shares, par value NIS 0.0000769 per share on August 7, 2026; holds 208,132 after (Direct).
- Grant/award: acquired 40,000 Stock Option (right to buy) on August 7, 2026; holds 40,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sean Ellis — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-07 | Grant/award | Ordinary Shares, par value NIS 0.0000769 per share | 20,034 | — | — | 208,132 |
| 2026-08-07 | Grant/award | Stock Option (right to buy) | 40,000 | — | — | 40,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-07 | Grant/award (20,034 shares) |
| 2026-08-07 | Grant/award (40,000 shares) |
Keywords
insider transaction, Form 4, ENTX, Entera Bio Ltd., neutral, Sean Ellis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.